Work

613P Chromosomal instability (CIN) biomarker in circulating tumor cells (CTC) may predict for therapy resistance in metastatic castration-resistant prostate cancer (mCRPC)

Year: 2021

Type: article

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2021.08.1126

Authors: N.M. Keegan, J. Schonhoft, E. Barnett, E.D. Cohn, J.L. Zhao, E.A. Carbone, M.R. Zanone, A. Anderson, R. Wenstrup, H.I. Scher

Institutions: Memorial Sloan Kettering Cancer Center, Epic Sciences (United States)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Prostate Cancer Foundation, Amgen, Pfizer, AstraZeneca, Sanofi, Menarini Silicon Biosystems, Y-mAbs Therapeutics, Astellas Pharma, Ipsen, Janssen Biotech

OpenAlex ID: W3204547298

FWCI:

Cites:

Cited by:

Related to: 10